136 related articles for article (PubMed ID: 12446957)
61. A prognostic DNA signature for T1T2 node-negative breast cancer patients.
Gravier E; Pierron G; Vincent-Salomon A; Gruel N; Raynal V; Savignoni A; De Rycke Y; Pierga JY; Lucchesi C; Reyal F; Fourquet A; Roman-Roman S; Radvanyi F; Sastre-Garau X; Asselain B; Delattre O
Genes Chromosomes Cancer; 2010 Dec; 49(12):1125-34. PubMed ID: 20842727
[TBL] [Abstract][Full Text] [Related]
62. Prediction of relapse in patients with breast cancer by DNA cytometry.
Machado-Santelli GM; Mori L; Pereira CA
Anal Cell Pathol; 1994 Dec; 7(4):321-34. PubMed ID: 7696156
[TBL] [Abstract][Full Text] [Related]
63. Genetic alterations in untreated metastases and androgen-independent prostate cancer detected by comparative genomic hybridization and allelotyping.
Cher ML; Bova GS; Moore DH; Small EJ; Carroll PR; Pin SS; Epstein JI; Isaacs WB; Jensen RH
Cancer Res; 1996 Jul; 56(13):3091-102. PubMed ID: 8674067
[TBL] [Abstract][Full Text] [Related]
64. Molecular evidence for progression of microglandular adenosis (MGA) to invasive carcinoma.
Shin SJ; Simpson PT; Da Silva L; Jayanthan J; Reid L; Lakhani SR; Rosen PP
Am J Surg Pathol; 2009 Apr; 33(4):496-504. PubMed ID: 19047897
[TBL] [Abstract][Full Text] [Related]
65. Genetic aberrations detected by comparative genomic hybridization predict outcome in node-negative breast cancer.
Isola JJ; Kallioniemi OP; Chu LW; Fuqua SA; Hilsenbeck SG; Osborne CK; Waldman FM
Am J Pathol; 1995 Oct; 147(4):905-11. PubMed ID: 7573366
[TBL] [Abstract][Full Text] [Related]
66. Chromosomal changes during development and progression of prostate adenocarcinomas.
Zitzelsberger H; Engert D; Walch A; Kulka U; Aubele M; Höfler H; Bauchinger M; Werner M
Br J Cancer; 2001 Jan; 84(2):202-8. PubMed ID: 11161378
[TBL] [Abstract][Full Text] [Related]
67. Genetic heterogeneity in a prostatic carcinoma and associated prostatic intraepithelial neoplasia as demonstrated by combined use of laser-microdissection, degenerate oligonucleotide primed PCR and comparative genomic hybridization.
Zitzelsberger H; Kulka U; Lehmann L; Walch A; Smida J; Aubele M; Lörch T; Höfler H; Bauchinger M; Werner M
Virchows Arch; 1998 Oct; 433(4):297-304. PubMed ID: 9808430
[TBL] [Abstract][Full Text] [Related]
68. Comparative genomic hybridization of formalin-fixed, paraffin-embedded breast tumors reveals different patterns of chromosomal gains and losses in fibroadenomas and diploid and aneuploid carcinomas.
Ried T; Just KE; Holtgreve-Grez H; du Manoir S; Speicher MR; Schröck E; Latham C; Blegen H; Zetterberg A; Cremer T
Cancer Res; 1995 Nov; 55(22):5415-23. PubMed ID: 7585611
[TBL] [Abstract][Full Text] [Related]
69. Heterogeneous chromosomal aberrations in intraductal breast lesions adjacent to invasive carcinoma.
Aubele M; Cummings M; Walsch A; Zitzelsberger H; Nährig J; Höfler H; Werner M
Anal Cell Pathol; 2000; 20(1):17-24. PubMed ID: 11007434
[TBL] [Abstract][Full Text] [Related]
70. A retrospective review with long term follow up of 11,400 cases of pure mucinous breast carcinoma.
Di Saverio S; Gutierrez J; Avisar E
Breast Cancer Res Treat; 2008 Oct; 111(3):541-7. PubMed ID: 18026874
[TBL] [Abstract][Full Text] [Related]
71. Ploidy differences between hormone- and chemical carcinogen-induced rat mammary neoplasms: comparison to invasive human ductal breast cancer.
Li JJ; Papa D; Davis MF; Weroha SJ; Aldaz CM; El-Bayoumy K; Ballenger J; Tawfik O; Li SA
Mol Carcinog; 2002 Jan; 33(1):56-65. PubMed ID: 11807958
[TBL] [Abstract][Full Text] [Related]
72. High-resolution genomic profiling to predict 10-year overall survival in node-negative breast cancer.
Möllerström E; Delle U; Danielsson A; Parris T; Olsson B; Karlsson P; Helou K
Cancer Genet Cytogenet; 2010 Apr; 198(2):79-89. PubMed ID: 20362222
[TBL] [Abstract][Full Text] [Related]
73. DNA copy number changes detected by comparative genomic hybridization and their association with clinicopathologic parameters in breast tumors.
Cingoz S; Altungoz O; Canda T; Saydam S; Aksakoglu G; Sakizli M
Cancer Genet Cytogenet; 2003 Sep; 145(2):108-14. PubMed ID: 12935921
[TBL] [Abstract][Full Text] [Related]
74. Genetic alterations in epithelial ovarian tumors analyzed by comparative genomic hybridization.
Hauptmann S; Denkert C; Koch I; Petersen S; Schlüns K; Reles A; Dietel M; Petersen I
Hum Pathol; 2002 Jun; 33(6):632-41. PubMed ID: 12152163
[TBL] [Abstract][Full Text] [Related]
75. Progression from colorectal adenoma to carcinoma is associated with non-random chromosomal gains as detected by comparative genomic hybridisation.
Meijer GA; Hermsen MA; Baak JP; van Diest PJ; Meuwissen SG; Beliën JA; Hoovers JM; Joenje H; Snijders PJ; Walboomers JM
J Clin Pathol; 1998 Dec; 51(12):901-9. PubMed ID: 10070331
[TBL] [Abstract][Full Text] [Related]
76. Chromosomal imbalances in Barrett's adenocarcinoma and the metaplasia-dysplasia-carcinoma sequence.
Walch AK; Zitzelsberger HF; Bruch J; Keller G; Angermeier D; Aubele MM; Mueller J; Stein H; Braselmann H; Siewert JR; Höfler H; Werner M
Am J Pathol; 2000 Feb; 156(2):555-66. PubMed ID: 10666385
[TBL] [Abstract][Full Text] [Related]
77. High survivin mRNA expression is a predictor of poor prognosis in breast cancer: a comparative study at the mRNA and protein level.
Xu C; Yamamoto-Ibusuki M; Yamamoto Y; Yamamoto S; Fujiwara S; Murakami K; Okumura Y; Yamaguchi L; Fujiki Y; Iwase H
Breast Cancer; 2014 Jul; 21(4):482-90. PubMed ID: 22968628
[TBL] [Abstract][Full Text] [Related]
78. Prognostic significance of recurrent chromosomal aberrations detected by comparative genomic hybridization in sporadic colorectal cancer.
De Angelis PM; Stokke T; Beigi M; Mjåland O; Clausen OP
Int J Colorectal Dis; 2001 Feb; 16(1):38-45. PubMed ID: 11317696
[TBL] [Abstract][Full Text] [Related]
79. High-resolution genomic profiling reveals association of chromosomal aberrations on 1q and 16p with histologic and genetic subgroups of invasive breast cancer.
Stange DE; Radlwimmer B; Schubert F; Traub F; Pich A; Toedt G; Mendrzyk F; Lehmann U; Eils R; Kreipe H; Lichter P
Clin Cancer Res; 2006 Jan; 12(2):345-52. PubMed ID: 16428471
[TBL] [Abstract][Full Text] [Related]
80. Prognostic value of breast cancer subtypes on breast cancer specific survival, distant metastases and local relapse rates in conservatively managed early stage breast cancer: a retrospective clinical study.
Sanpaolo P; Barbieri V; Genovesi D
Eur J Surg Oncol; 2011 Oct; 37(10):876-82. PubMed ID: 21824742
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
